FOLD. Amicus Therapeutics Announces Positive Pompe Program Updates AT2220-Enzyme Replacement Therapy (ERT) Co-Administration Increases Pompe Enzyme (rhGAA) Activity in First 3 Dose Cohorts in Phase 2 Study AT2220 Mitigates ERT-Related Immunogenicity in ex vivo Studies http://finance.yahoo.com/news/amicus-therapeutics-announces-positive-pompe-113000060.html